MedPath

Aortic Valve replAcement in eLective Patients From aOrtic Valve multiceNter Registry

Completed
Conditions
Aortic Valve Stenosis
Interventions
Procedure: Surgical Aortic Valve Replacement
Procedure: Transcutenous Aortic Valve Implantation
Registration Number
NCT05308173
Lead Sponsor
Nicolaus Copernicus University
Brief Summary

Multicenter registry data analysis of aortic valve stenosis patients that underwent elective, isolated transcutaneous aortic valve implantation (TAVI) or surgical aortic valve replacement between 2015 and 2019. In TAVI group only transfemoral access was considered.

Detailed Description

A retrospective analysis of the Multicenter Aortic Valve Registry patients operated between 2015 and 2019 in the three departments of cardiac surgery in Poland: the Medical University of Silesia in Katowice, Medical University in Gdańsk, and Poznań, University of Medical Science. Baseline clinical, procedural, and outcome data at follow-up were entered into prespecified electronic case report forms. Follow-up status was validated by personal contact or access to Polish National Health Fund. Patients with planned concomitant intervention on coronary arteries (by bypass grafting or percutaneous intervention), other valvular interventions, arrhythmia ablation, or left atrial appendage occlusion were excluded too. In TAVI group only femoral access was considered. For SAVR any tissue or mechanical valve implantation in an aortic position with sternotomy or minimal access was included.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2393
Inclusion Criteria
  • Age >18 years
  • Elective procedure
  • Aortic valve replacement with means of TAVI or SAVR
Exclusion Criteria
  • Concomitant procedures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Surgical Aortic Valve ReplacementSurgical Aortic Valve ReplacementSurgically replaced aortic valve. Patients with planned concomitant bypass grafting other valvular interventions, arrhythmia ablation, or left atrial appendage occlusion were excluded. Any tissue or mechanical valve implantation in an aortic position with sternotomy or minimal access was included.
Transcutaneous Aortic Valve ImplantationTranscutenous Aortic Valve ImplantationTransfemoral aortic valve implantation. Patients with a planned concomitant percutaneous coronary intervention were excluded
Primary Outcome Measures
NameTimeMethod
all-cause deathup to 6 years

death resulting from cardiovascular and non-cardiovascular causes

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath